“Novel Oral Anticoagulants in the Cardiac Catheterization and Laboratory: Which? When? Why?"

After this presentation, participants will be able to: learn about the currently available novel oral anticoagulants (NOACs); to understand the data of NOACs in patients going to the cardiac catheterization laboratory; to apply currently published data to direct patient care.


"Get the FAQs on NOACs"

After this presentation, participants will be able to: State the FDA-approved indications for use of the non-vitamin K oral anticoagulants (NOACs); understand the mechanism of action of the NOACs, in comparison to warfarin; know common side effects, drug interactions, and precautions for use of the NOACs;  develop a basic understanding of the pharmacokinetics of the NOACs and how they apply to recommendations for peri-procedural management;  and, be aware of where NOACs have been incorporated into evidence-based guidelines.

Session date: 
04/18/2017 - 8:00am to 9:00am CDT
Little Company of Mary Hospital
Evergreen Park, IL 60805
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Atman Shah, MD and Richard Mioni, PharmD